IVIS imaging showed in vivo localization of PS targeting antibodies and the Gla-EGF fusion protein to the tumors at 24 (Fig. S1C) and 48 h (Fig. S1D) after intraperitoneal injection, while isotype antibody showed minimal tumor localization. This evidence concerns the gene GLA and neoplasm.